Basit öğe kaydını göster

dc.contributor.authorYazilitas, D
dc.contributor.authorSendur, M.A.N
dc.contributor.authorKaraca, H
dc.contributor.authorOzdemir, N
dc.contributor.authorAksoy, S
dc.contributor.authorBerk, V
dc.contributor.authorYazici, O
dc.contributor.authorOztürk, B
dc.contributor.authorOzkan, M
dc.contributor.authorZengin, N
dc.contributor.authorAltundag, K.
dc.date.accessioned2019-12-10T11:12:15Z
dc.date.available2019-12-10T11:12:15Z
dc.date.issued2015
dc.identifier.urihttps://doi.org/10.7314/APJCP.2015.16.4.1471
dc.identifier.urihttps://www.scopus.com/inward/record.url?eid=2-s2.0-84926138033&partnerID=40&md5=a5e788169030d02b3c85890b4573dc61
dc.identifier.urihttp://hdl.handle.net/11655/15016
dc.relation.isversionof10.7314/APJCP.2015.16.4.1471
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleEfficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer: A retrospective study of the Anatolian Society of Medical Oncology
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalAsian Pacific Journal of Cancer Prevention
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume16
dc.identifier.issue4
dc.identifier.startpage1471
dc.identifier.endpage1477
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster